CVS Health Corp. closed 34.84% short of its 52-week high of $80.75, which the company achieved on March 28th.

We recently published a list of 12 Best Fortune 500 Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...

According to Benzinga Pro, CVS Health's peer group average for short interest as a percentage of float is 9.89%, which means ...

CVS Health Corp (CVS) stock saw a decline, ending the day at $51.96 which represents a decrease of $-0.18 or -0.35% from the prior close of $52.14. The stock opened at $51.43 and touched a low of $50.

Shocking revelations from a Federal Trade Commission, or FTC, investigation have exposed how three major prescription benefit managers, or PBMs, ...

The CEO of UnitedHealth Group defended the company's role in the U.S. health care system days after a report said the company ...

The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...

In past years we have discussed how opioid-related enforcement efforts have remained a top federal and state priority (here, ...

As pharmaceutical breakthroughs offer new treatment options, people are paying more attention to the coverage their employers ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.